Mylab partners with Shilpa Biologicals for vaccines and therapeutics segment
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Shilpa Biologicals has tie-ups with Zydus to supply ZyCoV-D vaccine drug substance and Dr Reddy’s to make Sputnik V from its facility in Dharwad
Newly formed Life Science Services business unit to offer fully integrated CDMO and Contract Testing Services
This is the ninth Covid-19 vaccine approved in India
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.
Narayanan to lead SeQuent through next phase of consolidation and growth
The recommended daily dose for Ryaltris is 2 sprays in each nostril twice daily
The last date to apply for this program is 18th January 2022
Flattish volume growth and subdued new launches were key factors for last month
Trastuzumab is monoclonal antibody used to treat human epidermal growth factor receptor 2 positive (HER2+) breast cancer and metastatic gastric cancers
Subscribe To Our Newsletter & Stay Updated